Cesar González-Blanch, PhD
- 2Articles
- 7.1KReads1
- 2006–2007Active
- 10Collaborators
About
Cesar González-Blanch, PhD, has published research focused on the clinical management of first-episode psychosis, particularly examining metabolic changes and weight gain associated with antipsychotic treatments such as haloperidol, olanzapine, and risperidone. His work includes randomized clinical trials evaluating pharmacological and behavioral interventions in drug-naive patients. His publications appeared between 2006 and 2007 in Psychiatrist.com.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
